CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)

BACKGROUND: Cytotoxic T-lymphocyte associated protein 4 (CTLA4) inhibitors have been shown to significantly prolong the overall survival (OS) in a wide range of cancers. However, its application in clear cell renal cell carcinoma (ccRCC) is limited due to the therapy response, and the prognostic val...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiyi, Wang, Feiyan, Tan, Wei, Zhang, Li, Dai, Fangfang, Wang, Yanqing, Fan, Yaqi, Yuan, Mengqin, Yang, Dongyong, Zheng, Yajing, Deng, Zhimin, Liu, Yeqiang, Cheng, Yanxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590466/
https://www.ncbi.nlm.nih.gov/pubmed/33117084
http://dx.doi.org/10.1186/s12935-020-01603-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590466/
https://www.ncbi.nlm.nih.gov/pubmed/33117084
http://dx.doi.org/10.1186/s12935-020-01603-2

Ejemplares similares